<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2020/05/26/healthy-clinical-trial-subjects-suffer-grade-3-side-effects-to-moderna_1920_s-mrna-covid19-vaccine.aspx</link><description>The first results from a coronavirus vaccine clinical trial are in, and of the 45 healthy persons who took Moderna&amp;rsquo;s mRNA COVID-19 vaccine, four suffered what is called Grade 3 side effects. The U.S. Department of Health and Human Services describes</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator><item><title>re: Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2020/05/26/healthy-clinical-trial-subjects-suffer-grade-3-side-effects-to-moderna_1920_s-mrna-covid19-vaccine.aspx?ShowAllComments=True#1002263</link><pubDate>5/28/2020 8:58:17 AM</pubDate><guid isPermaLink="false">24451277-a5aa-4add-96dc-64081bfd86fa:1002263</guid><dc:creator>Gwyncann</dc:creator><description>&lt;p&gt;Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus 2012&lt;/p&gt;
&lt;p&gt;&lt;a rel="nofollow" target="_new" href="https://pdfs.semanticscholar.org/962c/58e6dc9c1ea550eb51ce70b0d7c83dc7eff6.pdf"&gt;pdfs.semanticscholar.org/.../58e6dc9c1ea550eb51ce70b0d7c83dc7eff6.pdf&lt;/a&gt; &lt;/p&gt;
</description></item></channel></rss>